Ru Wang
Capital Medical University
66 Papers
72 Citations
Ru Wang is an academic researcher from Capital Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 38 publications. Previous affiliations of Ru Wang include Chinese Ministry of Education.
Chat about Author
Papers
SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Zhihong Ma,Hong Zhang,Meng Lian,Changli Yue,Gehong Dong,Yulan Jin,Rui Li,Hongfei Wan,Ru Wang,Ying Wang,Jie Zhai,Hongzhi Ma,Ling Feng,Jianfeng Han,Shuzhou Liu,Youxin Guo,Jianhua Li,Yu Liu,J G Fang,Honggang Liu +19 more
TL;DR: Immunohistochemical and RT-PCR results and knockdown experiments revealed that SLC7A11 was involved in the progression of LSCC, and may provide clinical information for the evaluation of OS rates and postoperative recurrence of LS CC.
Microarray Gene Expression Analysis of Tumorigenesis and Regional Lymph Node Metastasis in Laryngeal Squamous Cell Carcinoma
TL;DR: A gene expression signature of tumorigenesis and regional lymph node metastasis in laryngeal squamous cell carcinoma is revealed and will contribute to the understanding of the molecular basis of LSCC and help to improve diagnosis and treatment.
Prognostic Factors of Sinonasal Squamous Cell Carcinomas Arising De Novo and From Inverted Papilloma.
Yunxia Li,Chengshuo Wang,Ru Wang,Jiamin Zhang,Honggang Liu,Qian Shi,Xiaohong Chen,Lizhen Hou,Hongzhi Ma,Qi Zhong,Pingdong Li,Ling Feng,Shizhi He,Luo Zhang,Jugao Fang +14 more
TL;DR: Age, tumor stage and surgical positive margin are key factors for poor prognosis and should be routinely taken into consideration during treatment planning and subsequent surveillance.
18
Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
Ru Wang,Yichao Guo,Hongzhi Ma,Lin Feng,Qi Wang,Xiaohong Chen,Meng Lian,Haizhou Wang,Jugao Fang +8 more
TL;DR: Tumor necrosis factor superfamily member 13 may be a potential novel molecular target for diagnosis and prognosis in human LSCC, and therapies that target TNFSF13 may have clinical significance for the treatment of LSCC.
16
LINC00460 Promotes Cell Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Head and Neck Squamous Cell Carcinoma via miR-320a/BGN Axis.
TL;DR: Zhang et al. as discussed by the authors investigated the biological role of long non-coding RNAs and the mechanisms underlying epithelial-mesenchymal transition (EMT) in HNSCC.